公开(公告)号：US20100093870A1

公开(公告)日：2010-04-15

申请号：US12467383

申请日：2009-05-18

申请人： Madhur Ray ,  Raghwendra Pal ,  Satyawan Singh ,  Nandoo Mal Khanna

发明人： Madhur Ray ,  Raghwendra Pal ,  Satyawan Singh ,  Nandoo Mal Khanna

IPC分类号： A61K31/12 ,  A61P9/10

CPC分类号： A61K31/121 ,  A61K31/12 ,  A61K36/9066 ,  Y02A50/395 ,  A61K2300/00

摘要： The present invention relates to A composition obtained from the lipid soluble extract of rhizomes and leaves of Curcuma species of Zingiberaceae family, useful for the treatment of neurocerebrovascular disorders, said composition comprising fraction A consisting of ar-turmerone of formula 1, and turmerone of formula 2, and/or along with fraction B consisting of curcumene and zingiberine, and/or fraction C consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol, curcumenone, and curlone, and/or pharmaceutically acceptable additives and a method of treating neurocerebrovascular disorders in animals including humans using said composition by administering therapeutically effective amount of lipid soluble extract.

摘要翻译： 本发明涉及从根茎的脂溶性提取物和姜科科植物种的叶子获得的组合物，其可用于治疗神经性血管性疾病，所述组合物包含由式1的阿曲霉酮组成的级分A和式1的姜黄酮 和/或与由姜黄素和芝麻素组成的级分B和/或由克拉酮酮，姜黄酮，泽达隆，积雪草二烯，异喹硫醚，姜黄酮和卷曲酮组成的级分C和/或药学上可接受的添加剂和治疗神经性血管性血管病变的方法 在包括使用所述组合物的人的动物中，通过施用治疗有效量的脂溶性提取物。

公开(公告)号：US06991814B2

公开(公告)日：2006-01-31

申请号：US10319373

申请日：2002-12-13

申请人： Madhur Ray ,  Raghwendra Pal ,  Satyawan Singh ,  Nandoo Mal Khanna

发明人： Madhur Ray ,  Raghwendra Pal ,  Satyawan Singh ,  Nandoo Mal Khanna

IPC分类号： A61K35/78

CPC分类号： A61K31/121 ,  A61K31/12 ,  A61K36/9066 ,  A61K2300/00

摘要： The present invention relates to A composition obtained from the lipid soluble extract of rhizomes and leaves of Curcuma species of Zingiberaceae family, useful for the treatment of neurocerebrovascular disorders, said composition comprising fraction A consisting of ar-turmerone of formula 1, and turmerone of formula 2, and/or along with fraction B consisting of curcumene and zingiberine, and/or fraction C consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol, curcumenone, and curlone, and/or pharmaceutically acceptable additives and a method of treating neurocerebrovascular disorders in animals including humans using said composition by administering therapeutically effective amount of lipid soluble extract.

摘要翻译： 本发明涉及从根茎的脂溶性提取物和姜科科植物种的叶子获得的组合物，其可用于治疗神经性血管性疾病，所述组合物包含由式1的阿曲霉酮组成的级分A和式1的姜黄酮 和/或与由姜黄素和芝麻素组成的级分B和/或由克拉酮酮，姜黄酮，泽达隆，积雪草二烯，异喹硫醚，姜黄酮和卷曲酮组成的级分C和/或药学上可接受的添加剂和治疗神经性血管性血管病变的方法 在包括使用所述组合物的人的动物中，通过施用治疗有效量的脂溶性提取物。

公开(公告)号：US20060141024A1

公开(公告)日：2006-06-29

申请号：US11022929

申请日：2004-12-28

申请人： Renu Tripathi ,  Sunil Puri ,  Jagdishwar Srivastava ,  Satyawan Singh ,  Omkar Asthana ,  Anil Dwivedi

发明人： Renu Tripathi ,  Sunil Puri ,  Jagdishwar Srivastava ,  Satyawan Singh ,  Omkar Asthana ,  Anil Dwivedi

IPC分类号： A61K9/48 ,  A61K9/20 ,  A61K31/505 ,  A61K31/335

CPC分类号： A61K9/0019 ,  A61K9/1611 ,  A61K9/1617 ,  A61K9/1623 ,  A61K31/335 ,  A61K31/505 ,  Y02A50/411 ,  A61K2300/00

摘要： The present invention relates to a method for preparation of synergistic combination kits of α,β-arteether, sulfadoxin and pyrimethamine for the treatment of severe/multi-drug resistant cerebral malaria.

摘要翻译： 本发明涉及用于治疗严重/多重耐药性脑疟疾的α，β-胂醚，磺胺多辛和乙胺嘧啶的协同组合试剂盒的方法。

公开(公告)号：US20060051438A1

公开(公告)日：2006-03-09

申请号：US11210567

申请日：2005-08-24

申请人： Madhur Ray ,  Raghwendra Pal ,  Satyawan Singh ,  Nandoo Khanna

发明人： Madhur Ray ,  Raghwendra Pal ,  Satyawan Singh ,  Nandoo Khanna

IPC分类号： A61K36/9066

CPC分类号： A61K31/121 ,  A61K31/12 ,  A61K36/9066 ,  Y02A50/395 ,  A61K2300/00

摘要： The present invention relates to A composition obtained from the lipid soluble extract of rhizomes and leaves of Curcuma species of Zingiberaceae family, useful for the treatment of neurocerebrovascular disorders, said composition comprising fraction A consisting of ar-turmerone of formula 1, and turmerone of formula 2, and/or along with fraction B consisting of curcumene and zingiberine, and/or fraction C consisting of germacrone, curcumerone, zedoarone, sedoarondiol, isozdedoaronidiol, curcumenone, and curlone, and/or pharmaceutically acceptable additives and a method of treating neurocerebrovascular disorders in animals including humans using said composition by administering therapeutically effective amount of lipid soluble extract.